Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The capsule polysaccharide from serogroups A, B, C, W, and Y meningococci inhibits C1q interaction with bound anti-fHbp and anti-porin A antibodies, and, consequently, the deposition of C4b and classical complement pathway (Jarvis and Vedros, 1987), as well as LOS sialylation (Vogel et al., 1997), limits C3 deposition, inhibiting the alternative pathway
General Subcutaneous Injection Process Clean the injection area with an alcohol swab and allow to dry completely Draw the appropriate dose into an insulin syringe (29-31 gauge, 0.5 inch needle) Pinch a fold of skin and subcutaneous tissue between thumb and forefinger Insert the needle at a 45-degree angle into the pinched skin fold Release the skin fold and inject slowly over 5-10 seconds Withdraw needle and apply gentle pressure with a cotton ball if needed Do not rub or massage the injection site Wrist-Specific Injection Sites Local injection near the injury delivers higher peptide concentrations to target tissue compared to distant systemic injection
doi: 10.1111/j.1365-2567.2004.01821.x 305 CleareAJHeapEMalhiGSWesselySOKeaneVMiellJ
Reconstitution BPC-157 ships as a lyophilized (freeze-dried) powder
A brand-new systematic review just hit the journals, and its the most comprehensive look weve seen yet at the mechanism, the MSK outcomes, and the massive safety gray areas surrounding this compound
US$ 22.53
US$ 23.73
US$ 25.90
US$ 27.86
US$ 24.92
US$ 29.03
US$ 24.47
US$ 23.11
